³ÉÈËVRÊÓƵ

How we move forward through the next stage of the pandemic depends a great deal on how we manage the ongoing threat of emerging variants.

Please join us for our fifth event with - a panel discussion with COVID-19 Immunity Task Force (CITF)-funded experts researching variants of concern, held in collaboration with the (CoVaRR-Net).

Our panellists will answer a series of COVID-19-related questions, including:

• Where do COVID-19 variants come from?
• Who is most at risk for COVID-19 variants?
• Will new vaccines be required to combat future variants?
• What could endemicity and a world with regularly emerging variants of concern look like?

Please join us on Wednesday, February 23, 2022, from 11:30 AM – 12:30 PM (EST) for the discussion which will be followed by a question-and-answer session with the attendees.

Please note that this is a bilingual event and will be translated live for both our English and French participants. To activate the simultaneous translation feature, simply click on the globe icon at the bottom of your screen once you have joined the Zoom conference on the day of the event.

.

MODERATOR
Dr. Catherine Hankins, ³ÉÈËVRÊÓƵ; Co-Chair of the COVID-19 Immunity Task Force

PANELLISTS
Dr. Mark Brockman, Simon Fraser University; Immunology & Vaccine Protection Pillar Deputy, CoVaRR-Net
Dr. Anne-Claude Gingras, Lunenfeld-Tanenbaum Research Institute, University of Toronto; Functional Genomics & Structure-Function of Variants of Concern Pillar Lead, CoVaRR-Net
Dr. Marc-André Langlois, University of Ottawa; Executive Director, CoVaRR-Net
Dr. Jun Liu, University of Toronto
Dr. Ciriaco Piccirillo, Research Institute of the ³ÉÈËVRÊÓƵ Health Centre; Immunology & Vaccine Protection Pillar Co-Lead, CoVaRR-Net
Dr. Jeff Wrana, Lunenfeld-Tanenbaum Research Institute, University of Toronto; Viral Genomics & Sequencing Pillar Deputy, CoVaRR-Net